These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29061579)

  • 21. [Sudden cardiac death in young men].
    Perings C; Schoebel FC; Hennersdorf M; Vester EG; Strauer BE
    Dtsch Med Wochenschr; 1996 Sep; 121(38):1169-75. PubMed ID: 8925738
    [No Abstract]   [Full Text] [Related]  

  • 22. Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy: data from the German device registry.
    Frommeyer G; Reinke F; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Eckardt L
    Clin Res Cardiol; 2020 Apr; 109(4):508-512. PubMed ID: 31367999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of sudden death in end-stage hypertrophic cardiomyopathy.
    Kawarai H; Kajimoto K; Minami Y; Hagiwara N; Kasanuki H
    J Card Fail; 2011 Jun; 17(6):459-64. PubMed ID: 21624733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertrophic cardiomyopathy: management issues in the new millennium.
    Thaman R; Firoozi S; Hamid MS; McKenna WJ
    Curr Cardiol Rep; 2002 May; 4(3):226-32. PubMed ID: 11960592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertrophic cardiomyopathy: prognostic factors and survival analysis in 128 Egyptian patients.
    El-Saiedi SA; Seliem ZS; Esmail RI
    Cardiol Young; 2014 Aug; 24(4):702-8. PubMed ID: 23895893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Athlete's heart and hypertrophic cardiomyopathy: contribution on clinical and morphologic differentiation].
    Bahlmann E; Kuck KH; Nienaber CA
    Dtsch Med Wochenschr; 2015 Jul; 140(15):1158-64. PubMed ID: 26230069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy.
    Norrish G; Ding T; Field E; McLeod K; Ilina M; Stuart G; Bhole V; Uzun O; Brown E; Daubeney PEF; Lota A; Linter K; Mathur S; Bharucha T; Kok KL; Adwani S; Jones CB; Reinhardt Z; Omar RZ; Kaski JP
    Europace; 2019 Oct; 21(10):1559-1565. PubMed ID: 31155643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ
    Circulation; 2010 Jan; 121(3):445-56. PubMed ID: 20100987
    [No Abstract]   [Full Text] [Related]  

  • 29. Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.
    Songsirisuk N; Kittipibul V; Methachittiphan N; Charoenattasil V; Zungsontiporn N; Spanuchart I; Buppajarntham S; Mankongpaisarnrung C; Satitthummanid S; Srimahachota S; Chattranukulchai P; Boonyaratavej Songmuang S; Puwanant S
    BMC Cardiovasc Disord; 2019 Jan; 19(1):1. PubMed ID: 30606129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sudden cardiac death in hypertrophic cardiomyopathy.
    Malanuk RM; Nielsen CD; Spencer WH
    J S C Med Assoc; 2001 Oct; 97(10):424-7. PubMed ID: 11688312
    [No Abstract]   [Full Text] [Related]  

  • 31. How to Image Hypertrophic Cardiomyopathy.
    Maron MS; Rowin EJ; Maron BJ
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28701526
    [No Abstract]   [Full Text] [Related]  

  • 32. The electrocardiogram and the phenotypic expression of hypertrophic cardiomyopathy.
    Caselli S; Pelliccia A
    Eur Heart J; 2019 Mar; 40(12):982-985. PubMed ID: 30010740
    [No Abstract]   [Full Text] [Related]  

  • 33. Syncope and risk of sudden death in hypertrophic cardiomyopathy.
    Spirito P; Autore C; Rapezzi C; Bernabò P; Badagliacca R; Maron MS; Bongioanni S; Coccolo F; Estes NA; Barillà CS; Biagini E; Quarta G; Conte MR; Bruzzi P; Maron BJ
    Circulation; 2009 Apr; 119(13):1703-10. PubMed ID: 19307481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Begley DA; Mohiddin SA; Tripodi D; Winkler JB; Fananapazir L
    Pacing Clin Electrophysiol; 2003 Sep; 26(9):1887-96. PubMed ID: 12930505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
    Chan RH; Maron BJ; Olivotto I; Pencina MJ; Assenza GE; Haas T; Lesser JR; Gruner C; Crean AM; Rakowski H; Udelson JE; Rowin E; Lombardi M; Cecchi F; Tomberli B; Spirito P; Formisano F; Biagini E; Rapezzi C; De Cecco CN; Autore C; Cook EF; Hong SN; Gibson CM; Manning WJ; Appelbaum E; Maron MS
    Circulation; 2014 Aug; 130(6):484-95. PubMed ID: 25092278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy.
    Wang S; Cui H; Ji K; Song C; Ren C; Guo H; Zhu C; Wang S; Lai Y
    Cardiovasc Diabetol; 2020 May; 19(1):64. PubMed ID: 32404127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helical distribution of hypertrophy in patients with hypertrophic cardiomyopathy: prevalence and clinical implications.
    Viliani D; Pozo E; Aguirre N; Cecconi A; Olivera MJ; Caballero P; Jiménez-Borreguero LJ; Alfonso F
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1771-1780. PubMed ID: 28536896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk stratification in pediatric hypertrophic cardiomyopathy.
    Balaji S
    Heart Rhythm; 2024 Jan; 21(1):128-129. PubMed ID: 38176768
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy.
    Sorajja P; Nishimura RA; Ommen SR; Ackerman MJ; Tajik AJ; Gersh BJ
    J Am Soc Echocardiogr; 2006 Jun; 19(6):788-95. PubMed ID: 16762758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.